Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
September 22, 2020
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions offering, with advanced digital clinical tools for enhanced patient engagement, visibility, data capture, and analysis.
Avance Clinical made the announcement at BioPharm America (September 21-24, 2020)
Adelaide, Australia – The
leading Australian CRO for biotechs, and Frost & Sullivan 2020
Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions
offering, with advanced digital clinical tools for enhanced patient engagement,
visibility, data capture, and analysis. www.avancecro.com/eclinical-solutions
Avance Clinical
made the announcement at BioPharm America (September 21-24, 2020)
Avance Clinical’s
biotech clients now have the option to deploy the latest eClinical solutions to
maximise the value of study data and deliver real-time visibility on study
progress.
Avance
Clinical CEO Yvonne Lungershausen said:
“Our Data
Management team works with eClinical leaders such as Medrio to offer regulatory
compliant and patient centric tools for rapid start-up and continual data flow.
These tools improve patient engagement and data
collection and allow Sponsors to stay informed at every step with Sponsor
visible portals.”
The Avance
Clinical eClinical services include the following:
eSource
Direct data capture of source data on site
Forms customised by Avance Clinical Data
Management team
Edit checks built into forms; instant firing of
queries once data is entered
Option for data to be collected off-line and
synced when on-line is available
Fully integrated with Medrio EDC, data visible
for Sponsor review instantly
Remote monitoring and data review on ongoing
basis
Avance Clinical provision of tablets if required
eConsent
Electronic consent including patient sign-off and
investigator confirmation
Customisable to include animations, videos and
questions as required
Forms customised by Avance Clinical Data
Management team
Link via email to patient
Compatible with any device and internet system
(smart phones, tablet, laptop, desktop)
Integrated with Medrio EDC
Link can be shared with HREC as part of
submission package
ePRO
Electronic capture of patient reported outcome,
including diary data, dosing compliance, questionnaires, VAS/Pain scales
Forms customised by Avance Clinical Data
Management team
Link via email to patient
Options for emails and reminders at set times
during the day or week
Timezone adjusted to patient’s location
Compatible with any device and internet system
(smart phones, tablet, laptop, desktop)
Fully integrated with Medrio EDC, data visible
for Sponsor review instantly
Glynn Morrish, Avance Clinical Director Biometrics said:
“Direct electronic capture of study information and the complimentary
suite of solutions offered by Avance Clinical allows the company and its
clients to maximise clinical trial efficiency and flexibility while ensuring
data integrity is preserved.
Our highly trained and experienced biometrics team are excited to
continue to work at the forefront of innovation and technology and provide
services that offer stability and robustness to studies being conducted in an
ever-changing global environment.”
Avance Clinical is an Australian owned Contract Research Organisation
that has been providing high-quality clinical research services fit for global
regulatory standards to the local and international drug development industry
for 20 years.
About Avance Clinical www.avancecro.com
Australia’s Avance Clinical has more than 20-years of experience and is now one
of Australia’s leading Contract Research Organizations.
Avance Clinical is committed to providing
high-quality clinical research services with its highly-experienced team.
The collective pool of knowledge and experience at Avance Clinical continually
grows through the careful selection of experts who also demonstrate passion in
their chosen field.
Avance Clinical offers high-quality services in an established clinical trial
ecosystem, that includes world-class Investigators and Sites able to access
specialized patient groups.
Other benefits include: 1. The Government R&D grant means up to 43.5% rebate on clinical trial spend 2. eClinical solutions – speed and continuity 3. Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks 4. No IND required for clinical trials 5. Full GMP material is not mandated for Phase I clinical trials 6. Established clinical trial environment with world-class Investigators and sites 7. Established healthy subject databases and specialized patient populations 8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care 9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track-record in FDA compliant research 10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia’s counter-flu and allergy seasons